Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2009

Feb 4, 2009

34975_dirs_2009-02-04_34929807-39de-4ea6-b77c-0ed756f008d5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2009-02-02

Reporting Person: GREEN DAVID (Director, President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-02-02 Common Stock P 222 $2.49 Acquired 1422095 Direct
2009-02-02 Common Stock P 400 $2.48 Acquired 1422495 Direct
2009-02-02 Common Stock P 100 $2.47 Acquired 1422595 Direct
2009-02-03 Common Stock P 100 $2.49 Acquired 1422695 Direct

Footnotes

F1: Purchased pursuant to a stock trading plan established in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.